RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria

      한글로보기

      https://www.riss.kr/link?id=A107711978

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Salvage mastectomy is currently considered the standard of care for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and postoperative radiotherapy (RT). Alternative treatment options for these patients, such as a secon...

      Salvage mastectomy is currently considered the standard of care for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and postoperative radiotherapy (RT). Alternative treatment options for these patients, such as a second BCS followed by repeated RT, have been suggested.
      The panel of the Italian Association of Radiotherapy and Clinical Oncology developed clinical recommendations for second BCS followed by re-irradiation over mastectomy alone for women with IBTR using the Grades of Recommendation, Assessment, Development, and Evaluation methodology and the evidence to decision framework. The following outcomes were identified by the panel: locoregional control, metastasis-free survival, overall survival, and cancer-specific survival; acute and late toxicity, specific late toxicity, second locoregional tumor, and death related to treatment.
      An Embase and PubMed literature search was performed by two independent authors. Five retrospective observational studies were eligible for inclusion in the present analysis.
      According to the reports in the literature and our analysis, the advantages of second quadrantectomy and re-irradiation (re-QUART) outweigh its side effects, with overall good rates of survival and adequate toxicity without increasing costs.
      Given the very low level of evidence, the panel stated that a second BCS plus re-irradiation can be considered as an alternative to salvage mastectomy for selected patients with IBTR.

      더보기

      참고문헌 (Reference)

      1 Houvenaeghel G, "Survival after breast cancer local recurrence according to therapeutic strategies" 43 : 1409-1414, 2017

      2 Moran MS, "Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer" 88 : 553-564, 2014

      3 Smanykó V, "Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year results" 18 : 411-419, 2019

      4 Forster T, "Second breast conserving therapy after ipsilateral breast tumor recurrence-a 10-year experience of re-irradiation" 11 : 312-319, 2019

      5 Walstra CJ, "Repeat breast-conserving therapy for ipsilateral breast cancer recurrence : A systematic review" 45 : 1317-1327, 2019

      6 Arthur DW, "NRG oncology-radiation therapy oncology group study 1014 : 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence" 98 : 1028-1035, 2017

      7 AIOM, "Linee guida: neoplasia della mammella"

      8 Yoshida T, "Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer" 18 : 238-243, 2009

      9 Schünemann E, "Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach"

      10 Alonso-Coello P, "GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines" 353 : i2089-, 2016

      1 Houvenaeghel G, "Survival after breast cancer local recurrence according to therapeutic strategies" 43 : 1409-1414, 2017

      2 Moran MS, "Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer" 88 : 553-564, 2014

      3 Smanykó V, "Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year results" 18 : 411-419, 2019

      4 Forster T, "Second breast conserving therapy after ipsilateral breast tumor recurrence-a 10-year experience of re-irradiation" 11 : 312-319, 2019

      5 Walstra CJ, "Repeat breast-conserving therapy for ipsilateral breast cancer recurrence : A systematic review" 45 : 1317-1327, 2019

      6 Arthur DW, "NRG oncology-radiation therapy oncology group study 1014 : 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence" 98 : 1028-1035, 2017

      7 AIOM, "Linee guida: neoplasia della mammella"

      8 Yoshida T, "Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer" 18 : 238-243, 2009

      9 Schünemann E, "Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach"

      10 Alonso-Coello P, "GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines" 353 : i2089-, 2016

      11 Montagne L, "GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event" 176 : 149-157, 2019

      12 National Comprehensive Cancer Network, "Clinical practice guidelines in oncolgy v-1. 2019., breast cancer"

      13 World Health Organization, "Breast cancer incidence, mortality and prevalence worldwide"

      14 Hannoun-Levi JM, "Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence : multicentric study of the GEC-ESTRO Breast Cancer Working Group" 108 : 226-231, 2013

      15 Italian Association of Radiotherapy and Clinical Oncology, "AIRO - Associazione Italiana di Radioterapia ed Oncologia Clinica"

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-04-06 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> Journal of Breast Cancer KCI등재
      2011-03-23 학술지명변경 외국어명 : Journal of Korean Breast Cancer -> 미등록 KCI등재
      2011-03-04 학술지명변경 한글명 : 한국유방암학회지 -> Journal of Breast Cancer KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.99 0.19 1.31
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.96 0.77 0.448 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼